Immunocore Holdings plc (FRA:6YG)

Immunocore Holdings Statistics

Total Valuation

FRA:6YG has a market cap or net worth of EUR 1.29 billion. The enterprise value is 939.85 million.

Market Cap	1.29B
Enterprise Value	939.85M

Important Dates

The next estimated earnings date is Monday, August 10, 2026.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.94%
Shares Change (QoQ)	+4.89%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	88.14%
Float	42.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.61
PB Ratio	3.78
P/TBV Ratio	3.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-39.31
EV / Sales	2.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-35.25

Financial Position

The company has a current ratio of 4.18, with a Debt / Equity ratio of 1.11.

Current Ratio	4.18
Quick Ratio	3.86
Debt / Equity	1.11
Debt / EBITDA	n/a
Debt / FCF	-14.17
Interest Coverage	-1.21

Financial Efficiency

Return on equity (ROE) is -7.14% and return on invested capital (ROIC) is -1.12%.

Return on Equity (ROE)	-7.14%
Return on Assets (ROA)	-0.88%
Return on Invested Capital (ROIC)	-1.12%
Return on Capital Employed (ROCE)	-1.77%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	683,267
Profits Per Employee	-45,626
Employee Count	524
Asset Turnover	0.39
Inventory Turnover	37.13

Taxes

In the past 12 months, FRA:6YG has paid 13.58 million in taxes.

Income Tax	13.58M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-25.15%
50-Day Moving Average	25.17
200-Day Moving Average	27.94
Relative Strength Index (RSI)	52.41
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	22.33

Income Statement

In the last 12 months, FRA:6YG had revenue of EUR 358.03 million and -23.91 million in losses. Loss per share was -0.47.

Revenue	358.03M
Gross Profit	115.57M
Operating Income	-12.77M
Pretax Income	-10.33M
Net Income	-23.91M
EBITDA	-9.86M
EBIT	-12.77M
Loss Per Share	-0.47

Balance Sheet

The company has 732.78 million in cash and 377.87 million in debt, with a net cash position of 354.91 million.

Cash & Cash Equivalents	732.78M
Total Debt	377.87M
Net Cash	354.91M
Net Cash Per Share	n/a
Equity (Book Value)	341.43M
Book Value Per Share	6.72
Working Capital	662.35M

Cash Flow

In the last 12 months, operating cash flow was -21.61 million and capital expenditures -5.05 million, giving a free cash flow of -26.67 million.

Operating Cash Flow	-21.61M
Capital Expenditures	-5.05M
Depreciation & Amortization	2.89M
Net Borrowing	n/a
Free Cash Flow	-26.67M
FCF Per Share	n/a

Margins

Gross margin is 32.28%, with operating and profit margins of -3.57% and -6.68%.

Gross Margin	32.28%
Operating Margin	-3.57%
Pretax Margin	-2.89%
Profit Margin	-6.68%
EBITDA Margin	-2.75%
EBIT Margin	-3.57%
FCF Margin	n/a

Dividends & Yields

FRA:6YG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.94%
Shareholder Yield	-0.94%
Earnings Yield	-1.85%
FCF Yield	-2.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:6YG has an Altman Z-Score of 1.61 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.61
Piotroski F-Score	2